Document is current
Any future updates will be listed below
-
Authors
Li, Huanyu Z. https://orcid.org/0000-0002-5482-9936
Pike, Ashley C. W. https://orcid.org/0000-0001-9661-2607
Chang, Yung-Ning
Prakaash, Dheeraj
Gelova, Zuzana
Stanka, Josefina https://orcid.org/0009-0003-3173-703X
Moreau, Christophe
Scott, Hannah C.
Wunder, Frank https://orcid.org/0000-0002-1311-2357
Wolf, Gernot https://orcid.org/0000-0002-3943-8662
Scacioc, Andreea
McKinley, Gavin
Batoulis, Helena
Mukhopadhyay, Shubhashish
Garofoli, Andrea
Pinto-Fernández, Adán https://orcid.org/0000-0003-1693-9664
Kessler, Benedikt M. https://orcid.org/0000-0002-8160-2446
Burgess-Brown, Nicola A.
Štefanić, Saša https://orcid.org/0000-0001-7367-1831
Wiedmer, Tabea
Dürr, Katharina L. https://orcid.org/0000-0002-3245-4088
Puetter, Vera
Ehrmann, Alexander
Khalid, Syma https://orcid.org/0000-0002-3694-5044
Ingles-Prieto, Alvaro
Superti-Furga, Giulio https://orcid.org/0000-0002-0570-1768
Sauer, David B. https://orcid.org/0000-0001-9291-4640
-
Funding
Funding for this research was provided by:
Innovative Medicines Initiative (875510, 777372, 875510, 777372, 777372, 777372, 777372, 777372, 777372, 777372, 777372, 777372, 777372, 777372, 777372, 777372, 777372, 101034439)
- License Information
-
More Information
Article History
Received: 2 April 2024
Accepted: 3 January 2025
First Online: 16 January 2025
Competing interests
: J.S., F.W., H.B., and A.E. are employees of Bayer AG. Y.N.C. and V.P. are employees of Nuvisan ICB GmbH. G.S.F is co-founder and owns shares of Solgate GmbH, and SLC-focused company. The remaining authors declare no competing interests.
